- Zacks•5 days ago
ResMed Inc. (RMD) is slated to report third-quarter fiscal 2017 results, after market close on Apr 27.
- Zacks•12 days ago
ResMed Inc. (RMD) recently sponsored a study which shows potential treatment of obstructive sleep apnea (OSA) in patients with untreated central sleep apnea (CSA).
- Capital Cube•16 days ago
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ResMed, Inc. Here are 5 ETFs with the largest exposure to RMD-US. Comparing the performance and risk of ResMed, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
RMD : Summary for ResMed Inc. - Yahoo Finance
ResMed Inc. (RMD)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||68.35 - 69.93|
|52 Week Range||55.43 - 73.46|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||30.23|
|Dividend & Yield||1.32 (1.91%)|
|1y Target Est||N/A|